As a drug discovery bio-venture aiming to put HGF (hepatocyte growth factor) into practical use as a drug, we have established a process that can mass-produce "genetically modified human HGF" in "pharmaceutical grade". We are conducting clinical trials for intractable neurological diseases such as Spinal cord injury and ALS in order to obtain manufacturing and marketing approval. Many operating companies have formed capital and business alliances, and a system to support sales and distribution after obtaining approval has already been completed.